News Update Zafgen Granted Orphan Drug D

News Update Zafgen Granted Orphan Drug Designation in the European Union for Beloranib, a First-in-Class MetAP2 Inhibitor for the Treatment of Prader-Willi Syndrome http://ow.ly/2KuuNl

Advertisements